News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,020 Results
Type
Article (42412)
Company Profile (294)
Press Release (674314)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (210463)
Career Advice (2091)
Deals (36629)
Drug Delivery (108)
Drug Development (83060)
Employer Resources (175)
FDA (16563)
Job Trends (15403)
News (356057)
Policy (33904)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2597)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (51403)
ALS (90)
Alzheimer's disease (1387)
Antibody-drug conjugate (ADC) (119)
Approvals (16562)
Artificial intelligence (253)
Autoimmune disease (22)
Automation (15)
Bankruptcy (371)
Best Places to Work (11772)
BIOSECURE Act (19)
Biosimilars (109)
Biotechnology (188)
Bladder cancer (60)
Brain cancer (28)
Breast cancer (263)
Cancer (2110)
Cardiovascular disease (175)
Career advice (1750)
Career pathing (30)
CAR-T (145)
Cell therapy (408)
Cervical cancer (19)
Clinical research (67395)
Collaboration (807)
Compensation (506)
Complete response letters (25)
COVID-19 (2654)
CRISPR (43)
C-suite (229)
Cystic fibrosis (103)
Data (2061)
Decentralized trials (2)
Denatured (27)
Depression (42)
Diabetes (260)
Diagnostics (6433)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (108)
Drug shortages (28)
Duchenne muscular dystrophy (92)
Earnings (88056)
Editorial (35)
Employer branding (21)
Employer resources (149)
Events (114785)
Executive appointments (700)
FDA (17751)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (724)
Gene editing (107)
Generative AI (21)
Gene therapy (301)
GLP-1 (737)
Government (4524)
Grass and pollen (4)
Guidances (50)
Healthcare (18995)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (117)
Indications (27)
Infectious disease (2793)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (92)
Interviews (322)
IPO (16771)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (35)
Layoffs (481)
Leadership (17)
Legal (8375)
Liver cancer (73)
Lung cancer (303)
Lymphoma (141)
Machine learning (5)
Management (59)
Manufacturing (291)
MASH (64)
Medical device (13424)
Medtech (13429)
Mergers & acquisitions (20364)
Metabolic disorders (678)
Multiple sclerosis (74)
NASH (17)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1910)
NextGen: Class of 2025 (6637)
Non-profit (4525)
Northern California (2531)
Now hiring (37)
Obesity (367)
Opinion (228)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (80)
Parkinson's disease (147)
Partnered (21)
Patents (225)
Patient recruitment (100)
Peanut (49)
People (59179)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20907)
Phase II (29649)
Phase III (22225)
Pipeline (1121)
Policy (140)
Postmarket research (2654)
Preclinical (8863)
Press Release (68)
Prostate cancer (99)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (388)
Real estate (6257)
Recruiting (67)
Regulatory (23056)
Reports (46)
Research institute (2368)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (73)
Series A (127)
Series B (81)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2186)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3722)
State (2)
Stomach cancer (14)
Supply chain (67)
Tariffs (25)
The Weekly (50)
United States (22141)
Vaccines (681)
Venture capitalists (37)
Weight loss (248)
Women's health (34)
Worklife (15)
Date
Today (157)
Last 7 days (485)
Last 30 days (2525)
Last 365 days (33557)
2025 (9226)
2024 (35772)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47398)
2018 (35771)
2017 (33137)
2016 (32667)
2015 (38631)
2014 (32540)
2013 (27656)
2012 (29748)
2011 (30497)
2010 (28504)
Location
Africa (781)
Alabama (52)
Alaska (7)
Arizona (236)
Arkansas (14)
Asia (40630)
Australia (6512)
California (5782)
Canada (1943)
China (503)
Colorado (254)
Connecticut (263)
Delaware (136)
Europe (86698)
Florida (859)
Georgia (201)
Idaho (57)
Illinois (522)
India (26)
Indiana (307)
Iowa (9)
Japan (152)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (863)
Massachusetts (4376)
Michigan (217)
Minnesota (379)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (59)
New Hampshire (62)
New Jersey (1665)
New Mexico (29)
New York (1651)
North Carolina (956)
North Dakota (7)
Northern California (2531)
Ohio (194)
Oklahoma (14)
Oregon (38)
Pennsylvania (1306)
Puerto Rico (11)
Rhode Island (29)
South America (1161)
South Carolina (19)
South Dakota (1)
Southern California (2186)
Tennessee (98)
Texas (864)
Utah (172)
Virginia (143)
Washington D.C. (59)
Washington State (539)
West Virginia (3)
Wisconsin (53)
717,020 Results for "arrowhead pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
April 15, 2025
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 4, 2025
April 7, 2025
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results
February 10, 2025
·
11 min read
Press Releases
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity
February 25, 2025
·
7 min read
Biotech Beach
Arrowhead Pharmaceuticals to Participate in Upcoming June 2024 Conferences
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events.
May 31, 2024
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
February 10, 2025
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases
March 6, 2025
·
9 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results
January 23, 2025
·
4 min read
Biotech Beach
Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events.
April 29, 2024
·
6 min read
Drug Development
Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced plans to advance investigational plozasiran into a Phase 3 cardiovascular outcomes trial called CAPITAN.
June 25, 2024
·
12 min read
1 of 71,702
Next
